| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
---
|
|
Zacks Investment Research
2
(Buy)
|
|
Standard & Poor's
3 / 5 Stars
|
|
TheStreet.com
---
|
Fund Holdings
The fund invests in companies its management team believes are undervalued.
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 1.51 | 1.51 |
| Stocks | 98.49 | 98.49 |
| Bonds | 0.0 | 0.0 |
| Other | 0.0 | 0.0 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 0.0 | 0.0 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 04.30.2013
Top 10 Holdings
Performance as of 05.31.2013
Portfolio as of 04.30.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Occidental Petroleum Corporation | OXY | 23.89 | 3.66 |
| United Technologies Corp | UTX | 17.42 | 3.31 |
| Medtronic, Inc. | MDT | 27.55 | 3.26 |
| Hartford Financial Services Group Inc | HIG | 34.22 | 3.26 |
| Citigroup Inc | C | 31.4 | 3.17 |
| American International Group Inc | AIG | 26.77 | 3.11 |
| JPMorgan Chase & Co | JPM | 25.29 | 3.06 |
| Pfizer Inc | PFE | 12.56 | 3.0 |
| Microsoft Corporation | MSFT | 34.97 | 2.75 |
| Procter & Gamble Co | PG | 16.1 | 2.65 |
